Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding Zepbound and Mounjaro. Compounding of tirzepatide, ...

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs ...

Shares of Hims & Hers Health (HIMS) rallied on Tuesday after the telehealth company said it would begin selling branded versions of Eli ...

Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Rosie O'Donnell said she’s lost more weight since taking Mounjaro for her diabetes, admitting that she feels healthier and ...

Shares of Hims & Hers Health Inc. ended Tuesday over 5% higher, lifting retail investor mood after the telehealth company ...

But the FDA has approved weight loss drugs that contain the same active ingredients as Ozempic and Mounjaro. Wegovy (semaglutide) and Zepbound (tirzepatide) are prescription injections that are ...

Eli Lilly (LLY) is targeting additional drug compounders and telehealth companies that make copycat versions of its weight loss drug, with ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...